ETF Holdings Breakdown of EOLS

News associated with EOLS

Evolus (NASDAQ:EOLS) Shares Down 5.5% on Insider Selling

Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares dropped 5.5% on Tuesday following insider selling activity. The company traded as low as $9.31 and last traded at $9.42. Approximately 110,433 shares traded hands during trading, a decline of 88% from the average daily volume of 938,410 shares. The stock had previously closed at $9.96. Specifically, […] - 2025-06-18 05:10:53

Evolus (NASDAQ:EOLS) Shares Gap Up After Insider Buying Activity

Evolus, Inc. (NASDAQ:EOLS – Get Free Report) shares gapped up before the market opened on Wednesday following insider buying activity. The stock had previously closed at $9.87, but opened at $10.17. Evolus shares last traded at $10.38, with a volume of 256,876 shares. Specifically, Director Albert G. White III bought 20,000 shares of the company’s […] - 2025-06-12 05:15:00

Man Group plc Purchases Shares of 10,931 Evolus, Inc. (NASDAQ:EOLS)

Man Group plc purchased a new stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 10,931 shares of the company’s stock, valued at approximately $121,000. A number of other hedge funds also recently bought and sold shares […] - 2025-05-29 08:40:57

Nuveen Asset Management LLC Has $8.50 Million Stock Position in Evolus, Inc. (NASDAQ:EOLS)

Nuveen Asset Management LLC lowered its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 14.2% during the 4th quarter, Holdings Channel.com reports. The firm owned 769,576 shares of the company’s stock after selling 127,530 shares during the quarter. Nuveen Asset Management LLC’s holdings in Evolus were worth $8,496,000 as of its most […] - 2025-05-29 07:56:56

BNP Paribas Financial Markets Has $400,000 Position in Evolus, Inc. (NASDAQ:EOLS)

BNP Paribas Financial Markets cut its stake in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 42.3% during the 4th quarter, Holdings Channel reports. The fund owned 36,213 shares of the company’s stock after selling 26,535 shares during the period. BNP Paribas Financial Markets’ holdings in Evolus were worth $400,000 as of its most […] - 2025-05-26 07:24:47

Price T Rowe Associates Inc. MD Buys 6,332 Shares of Evolus, Inc. (NASDAQ:EOLS)

Price T Rowe Associates Inc. MD increased its stake in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 13.7% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 52,593 shares of the company’s stock after acquiring an additional 6,332 shares during the period. Price T Rowe Associates Inc. MD’s holdings in Evolus were worth […] - 2025-05-13 07:32:48

Schonfeld Strategic Advisors LLC Increases Position in Evolus, Inc. (NASDAQ:EOLS)

Schonfeld Strategic Advisors LLC lifted its position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 62.6% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 34,700 shares of the company’s stock after buying an additional 13,363 shares during the period. Schonfeld Strategic Advisors LLC’s holdings in […] - 2025-05-12 08:42:54

Evolus, Inc. (NASDAQ:EOLS) Shares Sold by Invesco Ltd.

Invesco Ltd. reduced its position in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 81.9% in the 4th quarter, HoldingsChannel.com reports. The fund owned 18,326 shares of the company’s stock after selling 83,072 shares during the quarter. Invesco Ltd.’s holdings in Evolus were worth $202,000 at the end of the most recent quarter. Other institutional investors […] - 2025-05-05 07:26:46

ExodusPoint Capital Management LP Purchases New Position in Evolus, Inc. (NASDAQ:EOLS)

ExodusPoint Capital Management LP acquired a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, Holdings Channel reports. The fund acquired 13,525 shares of the company’s stock, valued at approximately $149,000. A number of other hedge funds and other institutional investors have also added to or reduced their stakes […] - 2025-04-15 07:38:57

KLP Kapitalforvaltning AS Invests $106,000 in Evolus, Inc. (NASDAQ:EOLS)

KLP Kapitalforvaltning AS bought a new position in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 9,600 shares of the company’s stock, valued at approximately $106,000. Several other large investors have also recently added to or reduced their […] - 2025-04-11 08:14:55

Evolus, Inc. (NASDAQ:EOLS) Position Boosted by Intech Investment Management LLC

Intech Investment Management LLC raised its holdings in shares of Evolus, Inc. (NASDAQ:EOLS – Free Report) by 32.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,674 shares of the company’s stock after acquiring an additional 4,613 shares during the period. […] - 2025-03-27 08:29:02

HC Wainwright Reaffirms “Buy” Rating for Evolus (NASDAQ:EOLS)

Evolus (NASDAQ:EOLS – Get Free Report)‘s stock had its “buy” rating reissued by investment analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 100.00% from the stock’s current price. Several […] - 2025-03-07 06:50:44

China Universal Asset Management Co. Ltd. Acquires 1,291 Shares of Evolus, Inc. (NASDAQ:EOLS)

China Universal Asset Management Co. Ltd. grew its holdings in Evolus, Inc. (NASDAQ:EOLS – Free Report) by 10.6% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 13,426 shares of the company’s stock after acquiring an additional 1,291 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Evolus were worth $148,000 […] - 2025-02-04 08:53:02

EOLS institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-06-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	43,449	USD 404,510
2025-06-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	12,395	USD 115,397
2025-06-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	33,499	USD 311,876
2025-06-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	33,499	USD 311,876
Total =		122,842	USD 1,143,659

Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer